Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
NeoTRIPaPDL 1
Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1
- NCT02620280 ↗
- Completed
- Fondazione Michelangelo
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 7 | |
| YouTube | 2 |
The trial
ClinicalTrials.gov- Official title
- Neo-Adjuvant Study With the PDL1-directed Antibody in Triple Negative Locally Advanced Breast Cancer Undergoing Treatment With Nab-paclitaxel and Carboplatin
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Invasive Ductal Breast Carcinoma
- Interventions
- Carboplatin; Abraxane; MPDL3280A; Surgery; Anthra
- Arms
- Carbo-abrax, surgery, anthra · Active comparator
- Carbo-abrax-MPDL3280A, surgery, anthra · Experimental
- Enrollment
- 278
- Primary outcomes
- Event Free Survival (EFS)
- Sponsor
- Fondazione Michelangelo
- Start
- Apr 2016
- Primary completion
- Jan 2024
- Results posted
- No
- Registry record
- NCT02620280 · updated Mar 6, 2024
Publications
linked from the registry- Gianni L, Huang CS, Egle D, Bermejo B, Zamagni C, Thill M, Anton A, Zambelli S, Bianchini G, Russo S, Ciruelos EM, Greil R, Semiglazov V, Colleoni M, Kelly C, Mariani G, Del Mastro L, Maffeis I, Valagussa P, Viale G. Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study. Ann Oncol. 2022 May;33(5):534-543. doi: 10.1016/j.annonc.2022.02.004. Epub 2022 Feb 17. PubMed 35182721
- Perez-Garcia J, Soberino J, Racca F, Gion M, Stradella A, Cortes J. Atezolizumab in the treatment of metastatic triple-negative breast cancer. Expert Opin Biol Ther. 2020 Sep;20(9):981-989. doi: 10.1080/14712598.2020.1769063. Epub 2020 May 25. PubMed 32450725